查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
细胞健康筛查市场规模、份额和趋势分析报告：按测试类型（单测试面板、多测试面板）、样品类型（血液、尿液）、采样地点、地区、细分市场，2022-2030 年
市场调查报告书
商品编码
1133327

细胞健康筛查市场规模、份额和趋势分析报告：按测试类型（单测试面板、多测试面板）、样品类型（血液、尿液）、采样地点、地区、细分市场，2022-2030 年

Cellular Health Screening Market Size, Share & Trends Analysis Report By Test Type (Single Test Panels, Multi-test Panels), By Sample Type (Blood, Urine), By Collection Site, By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

细胞健康筛查市场增长和趋势

根据 Grand View Research, Inc. 的最新报告，到 2030 年，全球细胞健康筛查市场规模预计将达到 56.2 亿美元，从 2022 年到 2030 年以 9.2% 的复合年增长率增长。日益老龄化的人口以及随之而来的对细胞健康诊断需求的增加正在显着推动市场。此外，越来越多地采用直接面向消费者的方法，健康预期寿命 (HALE) 的重要性日益增加，端粒性能计划的增加以过上健康的生活，以及政府对预防医学日益增长的兴趣正在推动市场。

越来越多的人正在接受细胞健康筛查测试，例如端粒测试，以了解细胞衰老的生物标誌物，预计也将补充市场增长。已经证明，提供端粒长度和活动信息的测试也可以提供有关生活方式和压力源的信息。大量研究表明，急性和慢性压力都会加速细胞老化。因此，这些测试在了解健康状况方面发挥着重要作用。

通过研究运动、睡眠、心理健康问题、饮酒和吸烟习惯如何以不同方式改变细胞衰老，可以进一步了解细胞质量。端粒测试提供了对代谢和遗传疾病的洞察，使临床医生能够进行早期诊断并快速、个性化地调整患者治疗策略。因此，对细胞筛选和扩大研究的兴趣日益增加，增加了对试剂盒和测试的需求，推动了近年来的市场增长。

预防医学应用和了解端粒长度与衰老之间的关係越来越需要细胞筛选研究。随着时间的推移，通常建议使用基于生物细胞的筛查，以便患者可以比较结果并了解需要进行哪些校正。通过在筛查过程中监测细胞健康的变化，可以快速调整健康方案以改善整体疾病管理。

此外，与年龄有关的疾病与功能失调的旧细胞的积累有关。最近的研究表明，这些可以通过采用多种细胞健康方式来恢復，如几项动物研究所示。因此，在蛋白质表达、蛋白质组学和基因组学领域正在进行的研发活动有望在不久的将来进一步推动对细胞健康筛查产品的需求。

细胞健康诊断市场报告亮点

按检验类型分，2021年单一检验面板占比最大。这是由于高特异性、易于定制和改进的产品在市场上的可用性。

在单一测试面板细分市场中，氧化压力测试将在 2021 年占据最大份额。这些测试有助于癌症、呼吸系统疾病、糖尿病、心血管疾病和其他疾病。

根据样本类型，2021年血液样本部分占最大份额。传染病发病率的增加、新病原体的出现、对献血的需求增加以及献血数量的增加，导致对用于细胞健康筛查的血液样本的需求不断增加。

从收集地点来看，医院将在 2021 年占据最大的销售额份额。很大一部分普通人群使用这些长期设施来诊断、治疗和管理疾病，从而推动了这一细分市场。

2021年，北美将占据最大的市场份额。健康预期寿命 (HALE) 的重要性日益提高以及政府针对预防性医疗保健的举措越来越多，这些都是有望推动该地区市场增长的一些关键因素。

预计亚太地区将在预测期内增长最快。端粒功能计划的传播和意识以及对健康预期寿命的日益提高的意识正在促进该地区的增长。

目录

第一章 调查方法和范围

  • 市场细分和范围
  • 市场定义
  • 信息采购
    • 购买的数据库
    • GVR 内部数据库
    • 次要信息和第三方观点
    • 初步调查
  • 信息分析
    • 数据分析模型
  • 市场形成和数据可视化
  • 验证和发布数据

第二章执行摘要

  • 市场展望
  • 分部展望
  • 竞争考虑

3. 细胞健康筛查市场变量、趋势和范围

  • 市场系列展望
    • 母公司市场展望
    • 辅助市场展望
  • 绘製渗透率和增长前景
  • 市场动态
    • 市场驱动力分析
      • 增加端粒性能计划的采用以过上健康的生活
      • 健康调整后预期寿命 (HALE) 的重要性日益增加
      • 政府对预防保健的兴趣日益浓厚
      • 不断增长的老年人口导致对细胞健康筛查的需求增加
      • 增加调查活动
      • 越来越多地采用直接面向消费者的方法来提供套件
      • 慢性病负担加重
    • 市场约束分析
      • 样品运输问题
      • 各公司提供的检测试剂盒价格差异
    • 行业挑战
    • COVID-19 影响分析
  • 细胞健康筛查市场分析工具
    • 行业分析 - 搬运工
      • 供应商力量
      • 买方议价能力
      • 替代威胁
      • 来自新进入者的威胁
      • 竞争对手之间的竞争
    • PESTEL 分析
      • 政局
      • 环境状况
      • 社会局势
      • 科技景观
      • 法律状况

第 4 章细胞健康筛查市场 - 竞争分析

  • 主要市场参与者的最新发展和影响分析
  • 供应商情况
    • 按地区/国家划分的主要供应商/分销商/製造商列表
  • 上市公司
    • 公司市场分析
    • 竞争仪錶盘分析
  • 民营企业
    • 主要初创企业名单
    • 区域网络图
    • 公司市场分析

5 细胞健康筛查市场：测试类型估计和趋势分析

  • 定义和范围
  • 测试类型市场份额分析，2021 年和 2030 年
  • 细分仪表板
  • 2018-2030 年按测试类型划分的全球细胞健康筛查市场
  • 市场规模和预测，趋势分析，2018-2030
    • 单试板
      • 端粒测试
      • 氧化应激测试
      • 炎症试验
      • 重金属测试
    • 多试板

6 细胞健康筛查市场：样本类型估计和趋势分析

  • 定义和范围
  • 样本类型市场份额分析，2021 年和 2030 年
  • 细分仪表板
  • 2018-2030年全球细胞健康筛查市场样本类型
  • 市场规模和预测，趋势分析，2018-2030
    • 血液
    • 唾液
    • 血清
    • 尿

7 细胞健康筛查市场：收集站点的估计和趋势分析

  • 定义和范围
  • 2021 年和 2030 年收集站点市场份额分析
  • 细分仪表板
  • 2018-2030 年按收集站点划分的全球细胞健康筛查市场
  • 市场规模和预测，趋势分析，2018-2030
    • 房子
    • 办公室
    • 医院
    • 诊断实验室

第 8 章细胞健康筛查市场：区域估计和趋势分析

  • 区域市场快照
  • 2021年区域市场份额
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 2021年按国家/地区分列的市场份额分析
    • 北美
      • 美国
      • 加拿大
    • 欧洲
      • 英国
      • 德国
      • 西班牙
      • 法国
      • 意大利
      • 俄罗斯
    • 亚太地区
      • 日本
      • 中国
      • 印度
      • 韩国
      • 新加坡
      • 澳大利亚
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
    • 中东和非洲
      • 南非
      • 沙特阿拉伯
      • 阿拉伯联合酋长国
  • SWOT 因素分析（政治与法律、经济与技术）
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场规模和预测，趋势分析，2021 年和 2030 年
    • 北美
      • 美国
      • 加拿大
    • 欧洲
      • 英国
      • 德国
      • 西班牙
      • 法国
      • 意大利
      • 俄罗斯
    • 亚太地区
      • 日本
      • 中国
      • 印度
      • 韩国
      • 新加坡
      • 澳大利亚
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
    • 中东和非洲
      • 南非
      • 沙特阿拉伯
      • 阿拉伯联合酋长国

第九章公司简介

  • 公司简介
    • Telomere Diagnostics
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • SpectraCell Laboratories
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Life Length
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Repeat Diagnostics, Inc.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Cell Science Systems Corp.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Quest Diagnostics
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • LabCorp Holdings
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • OPKO
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Genova Diagnostics
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Immunodiagnostik AG
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • DNA Labs
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
Product Code: GVR-3-68038-972-2

Cellular Health Screening Market Growth & Trends:

The global cellular health screening market size is expected to reach USD 5.62 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 9.2% from 2022 to 2030. The growing geriatric population and consequent growth in the requirement for cellular health screening are majorly driving the market. In addition, the rising adoption of the direct-to-consumer approach, the growing importance of healthy life expectancy (HALE), increasing telomere performance programs for leading a healthy life, and rising government focus on preventive healthcare are expected to drive the market.

An increasing number of individuals undergoing cellular health screening testing, such as telomere tests, to learn about the biomarkers of cell aging is also anticipated to supplement the market growth. It has been demonstrated that tests that provide information on telomere length and activity can also provide information on lifestyle and stress factors. Numerous studies have demonstrated that both acute stress and chronic stress accelerate cell aging. Thus, these tests play an important role in understanding one's health.

Additionally, researchers can gain insights into cellular qualities by studying how physical exercise, sleep, mental health issues, alcohol use, and smoking habits alter cellular aging in various ways. The utilization of telomere tests offers insights into metabolic and genetic illnesses, enabling clinicians to make an early diagnosis and quickly and individually tailor a patient's treatment regimen. Consequently, growing interest in cellular screening and expanding research have increased kit and test demand, facilitating market growth in recent years.

The necessity for cellular screening research has grown as a result of its many applications in preventive medicine and the capacity to comprehend relationships between telomere length and aging. Bio-cell-based screenings are frequently advised throughout time, allowing patients to compare results and comprehend what modifications need to be made. Monitoring these alterations in cellular health between screenings enables quick adjustments to be made in terms of health protocols and a general improvement in illness management.

Furthermore, disorders related to aging are linked to the buildup of old, dysfunctional cells. As shown in several animal trials, research has recently established that these can be reversed by employing a variety of cellular health procedures. Consequently, it is anticipated that ongoing research and development activities in the disciplines of protein expression, proteomics, and genomics are anticipated to further boost the demand for cellular health screening products in the near future.

Cellular Health Screening Market Report Highlights:

  • By test type, single test panels held the largest share in 2021. This is attributed to high specificity, easy customization, and increasing product availability in the market
  • In the single test panels segment, the oxidative stress tests captured the largest share in 2021. These tests aid in cancer, respiratory diseases, diabetes, cardiovascular diseases, and other diseases
  • Based on sample type, the blood sample segment accounted for the largest share in 2021. The growing incidence of infectious diseases, emergence of newer pathogens, increasing demand for donated blood, and rising number of blood donations have contributed to the rising demand for blood samples for cellular health screening
  • By collection site, hospitals captured the largest revenue share in 2021. A major part of the general population relies on these long-term facilities for diagnosis, treatment, and management of diseases, thus driving the segment
  • North America accounted for the largest market share in 2021. An increase in the importance of Healthy Life Expectancy (HALE) and increasing number of government initiatives focused on preventive healthcare are some of the key factors expected to boost the market growth in the region
  • Asia Pacific is expected to witness the fastest growth throughout the forecast period. Improving adoption and awareness of telomere performance programs and growing awareness of healthy life expectancy have contributed to regional growth

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market segmentation & scope
  • 1.2 Market definition
  • 1.3 Information procurement
    • 1.3.1 Purchased database
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources & third party perspectives
    • 1.3.4 Primary research
  • 1.4 Information analysis
    • 1.4.1 Data analysis models
  • 1.5 Market formulation & data visualization
  • 1.6 Data validation & publishing

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
  • 2.3 Competitive Insights

Chapter 3 Cellular Health Screening Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Penetration and Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market driver analysis
      • 3.3.1.1 Rise in the adoption of telomere performance programs to lead a healthy life
      • 3.3.1.2 Increase in importance of health-adjusted life expectancy (HALE)
      • 3.3.1.3 Increasing government focus on preventive healthcare
      • 3.3.1.4 Rise in geriatric population leading to growth in the need for cellular health screening
      • 3.3.1.5 Increase in research activities
      • 3.3.1.6 Growth in the adoption of direct-to-consumer approach for the availability of kits
      • 3.3.1.7 Rise in burden of chronic diseases
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 Problems associated with the transport of samples
      • 3.3.2.2 Differences in the cost of test kits offered by different companies
    • 3.3.3 Industry challenges
    • 3.3.4 COVID-19 Impact Analysis
  • 3.4 Cellular Health Screening Market Analysis Tools
    • 3.4.1 Industry analysis - Porter's
      • 3.4.1.1 Supplier Power
      • 3.4.1.2 Buyer Power
      • 3.4.1.3 Substitution Threat
      • 3.4.1.4 Threat from new entrants
      • 3.4.1.5 Competitive Rivalry
    • 3.4.2 PESTEL Analysis
      • 3.4.2.1 Political Landscape
      • 3.4.2.2 Environmental Landscape
      • 3.4.2.3 Social landscape
      • 3.4.2.4 Technology landscape
      • 3.4.2.5 Legal Landscape

Chapter 4 Cellular Health Screening Market - Competitive Analysis

  • 4.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 4.2 Vendor Landscape
    • 4.2.1 List of Major Suppliers/Distributors/Manufacturers, By Region/Country
  • 4.3 Public Companies
    • 4.3.1 Company market position analysis
    • 4.3.2 Competitive dashboard analysis
  • 4.4 Private Companies
    • 4.4.1 List of key emerging companies
    • 4.4.2 Regional network map
    • 4.4.3 Company market position analysis

Chapter 5 Cellular Health Screening Market: Test Type Estimates And Trend Analysis

  • 5.1 Definition & Scope
  • 5.2 Test Type Market Share Analysis, 2021 & 2030
  • 5.3 Segment Dashboard
  • 5.4 Global Cellular Health Screening Market, by Test Type, 2018 to 2030
  • 5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 5.5.1 Single Test Panels
      • 5.5.1.1 Single Test Panels Market Estimates and Forecasts, 2018 to 2030 (USD Million)
      • 5.5.1.2 Telomere Tests
      • 5.5.1.2.1 Telomere Tests Market Estimates and Forecasts, 2018 to 2030 (USD Million)
      • 5.5.1.3 Oxidative Stress Tests
      • 5.5.1.3.1 Oxidative Stress Tests Market Estimates and Forecasts, 2018 to 2030 (USD Million)
      • 5.5.1.4 Inflammation Tests
      • 5.5.1.4.1 Inflammation Tests Market Estimates and Forecasts, 2018 to 2030 (USD Million)
      • 5.5.1.5 Heavy Metals Tests
      • 5.5.1.5.1 Heavy Metals Tests Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 5.5.2 Multi-test Panels
      • 5.5.2.1 Multi-test Panels Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 6 Cellular Health Screening Market: Sample Type Estimates And Trend Analysis

  • 6.1 Definition & Scope
  • 6.2 Sample Type Market Share Analysis, 2021 & 2030
  • 6.3 Segment Dashboard
  • 6.4 Global Cellular Health Screening Market, by Sample Type, 2018 to 2030
  • 6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 6.5.1 Blood
      • 6.5.1.1 Blood Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.5.2 Saliva
      • 6.5.2.1 Saliva Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.5.3 Serum
      • 6.5.3.1 Serum Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.5.4 Urine
      • 6.5.4.1 Urine Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 7 Cellular Health Screening Market: Collection Site Estimates And Trend Analysis

  • 7.1 Definition & Scope
  • 7.2 Collection Site Market Share Analysis, 2021 & 2030
  • 7.3 Segment Dashboard
  • 7.4 Global Cellular Health Screening Market, by Collection Site, 2018 to 2030
  • 7.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 7.5.1 Home
      • 7.5.1.1 Home Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 7.5.2 Office
      • 7.5.2.1 Office Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 7.5.3 Hospital
      • 7.5.3.1 Hospital Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 7.5.4 Diagnostic Labs
      • 7.5.4.1 Diagnostic Labs Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 8 Cellular Health Screening Market: Regional Estimates & Trend Analysis

  • 8.1 Regional Market Snapshot
  • 8.2 Regional Market Share, 2021
    • 8.2.1 North America
    • 8.2.2 Europe
    • 8.2.3 Asia Pacific
    • 8.2.4 Latin America
    • 8.2.5 Middle East & Africa
  • 8.3 Market Share Analysis by Country, 2021
    • 8.3.1 North America
      • 8.3.1.1 U.S.
      • 8.3.1.2 Canada
    • 8.3.2 Europe
      • 8.3.2.1 U.K.
      • 8.3.2.2 Germany
      • 8.3.2.3 Spain
      • 8.3.2.4 France
      • 8.3.2.5 Italy
      • 8.3.2.6 Russia
    • 8.3.3 Asia Pacific
      • 8.3.3.1 Japan
      • 8.3.3.2 China
      • 8.3.3.3 India
      • 8.3.3.4 South Korea
      • 8.3.3.5 Singapore
      • 8.3.3.6 Australia
    • 8.3.4 Latin America
      • 8.3.4.1 Brazil
      • 8.3.4.2 Mexico
      • 8.3.4.3 Argentina
    • 8.3.5 Middle East & Africa
      • 8.3.5.1 South Africa
      • 8.3.5.2 Saudi Arabia
      • 8.3.5.3 UAE
  • 8.4 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 8.4.1 North America
    • 8.4.2 Europe
    • 8.4.3 Asia Pacific
    • 8.4.4 Latin America
    • 8.4.5 Middle East & Africa
  • 8.5 Market Size & Forecasts, and Trend Analysis, 2021 & 2030
    • 8.5.1 North America
      • 8.5.1.1 North America Market Size & Forecasts and Trend Analysis, 2018 to 2030 (USD Million)
      • 8.5.1.2 U.S.
      • 8.5.1.2.1 U.S. Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.1.2.2 U.S. Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.1.2.3 U.S. Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)
      • 8.5.1.3 Canada
      • 8.5.1.3.1 Canada Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.1.3.2 Canada Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.1.3.3 Canada Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)
    • 8.5.2 Europe
      • 8.5.2.1 Europe Market Size & Forecasts and Trend Analysis, 2018 to 2030 (USD Million)
      • 8.5.2.2 U.K.
      • 8.5.2.2.1 U.K. Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.2.2.2 U.K. Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.2.2.3 U.K. Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)
      • 8.5.2.3 Germany
      • 8.5.2.3.1 Germany Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.2.3.2 Germany Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.2.3.3 Germany Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)
      • 8.5.2.4 Spain
      • 8.5.2.4.1 Spain Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.2.4.2 Spain Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.2.4.3 Spain Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)
      • 8.5.2.5 France
      • 8.5.2.5.1 France Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.2.5.2 France Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.2.5.3 France Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)
      • 8.5.2.6 Italy
      • 8.5.2.6.1 Italy Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.2.6.2 Italy Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.2.6.3 Italy Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)
      • 8.5.2.7 Russia
      • 8.5.2.7.1 Russia Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.2.7.2 Russia Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.2.7.3 Russia Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)
    • 8.5.3 Asia Pacific
      • 8.5.3.1 Asia Pacific Market Size & Forecasts and Trend Analysis, 2018 to 2030 (USD Million)
      • 8.5.3.2 Japan
      • 8.5.3.2.1 Japan Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.3.2.2 Japan Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.3.2.3 Japan Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)
      • 8.5.3.3 China
      • 8.5.3.3.1 China Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.3.3.2 China Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.3.3.3 China Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)
      • 8.5.3.4 India
      • 8.5.3.4.1 India Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.3.4.2 India Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.3.4.3 India Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)
      • 8.5.3.5 South Korea
      • 8.5.3.5.1 South Korea Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.3.5.2 South Korea Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.3.5.3 South Korea Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)
      • 8.5.3.6 Singapore
      • 8.5.3.6.1 Singapore Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.3.6.2 Singapore Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.3.6.3 Singapore Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)
      • 8.5.3.7 Australia
      • 8.5.3.7.1 Australia Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.3.7.2 Australia Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.3.7.3 Australia Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)
    • 8.5.4 Latin America
      • 8.5.4.1 Latin America Market Size & Forecasts and Trend Analysis, 2018 to 2030 (USD Million)
      • 8.5.4.2 Brazil
      • 8.5.4.2.1 Brazil Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.4.2.2 Brazil Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.4.2.3 Brazil Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)
      • 8.5.4.3 Mexico
      • 8.5.4.3.1 Mexico Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.4.3.2 Mexico Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.4.3.3 Mexico Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)
      • 8.5.4.4 Argentina
      • 8.5.4.4.1 Argentina Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.4.4.2 Argentina Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.4.4.3 Argentina Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)
    • 8.5.5 Middle East & Africa
      • 8.5.5.1 Middle East & Africa Market Size & Forecasts and Trend Analysis, 2018 to 2030 (USD Million)
      • 8.5.5.2 South Africa
      • 8.5.5.2.1 South Africa Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.5.2.2 South Africa Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.5.2.3 South Africa Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)
      • 8.5.5.3 Saudi Arabia
      • 8.5.5.3.1 Saudi Arabia Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.5.3.2 Saudi Arabia Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.5.3.3 Saudi Arabia Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)
      • 8.5.5.4 UAE
      • 8.5.5.4.1 UAE Market Size & Forecasts and Trend Analysis, By Test Type, 2018 to 2030 (USD Million)
      • 8.5.5.4.2 UAE Market Size & Forecasts and Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
      • 8.5.5.4.3 UAE Market Size & Forecasts and Trend Analysis, By Collection Site, 2018 to 2030 (USD Million)

Chapter 9 Company Profile

  • 9.1 Company Profiles
    • 9.1.1 Telomere Diagnostics
      • 9.1.1.1 Company overview
      • 9.1.1.2 Financial Performance
      • 9.1.1.3 Product benchmarking
      • 9.1.1.4 Strategic initiatives
    • 9.1.2 SpectraCell Laboratories
      • 9.1.2.1 Company overview
      • 9.1.2.2 Financial Performance
      • 9.1.2.3 Product benchmarking
      • 9.1.2.4 Strategic initiatives
    • 9.1.3 Life Length
      • 9.1.3.1 Company overview
      • 9.1.3.2 Financial Performance
      • 9.1.3.3 Product benchmarking
      • 9.1.3.4 Strategic initiatives
    • 9.1.4 Repeat Diagnostics, Inc.
      • 9.1.4.1 Company overview
      • 9.1.4.2 Financial Performance
      • 9.1.4.3 Product benchmarking
      • 9.1.4.4 Strategic initiatives
    • 9.1.5 Cell Science Systems Corp.
      • 9.1.5.1 Company overview
      • 9.1.5.2 Financial Performance
      • 9.1.5.3 Product benchmarking
      • 9.1.5.4 Strategic initiatives
    • 9.1.6 Quest Diagnostics
      • 9.1.6.1 Company overview
      • 9.1.6.2 Financial Performance
      • 9.1.6.3 Product benchmarking
      • 9.1.6.4 Strategic initiatives
    • 9.1.7 LabCorp Holdings
      • 9.1.7.1 Company overview
      • 9.1.7.2 Financial Performance
      • 9.1.7.3 Product benchmarking
      • 9.1.7.4 Strategic initiatives
    • 9.1.8 OPKO
      • 9.1.8.1 Company overview
      • 9.1.8.2 Financial Performance
      • 9.1.8.3 Product benchmarking
      • 9.1.8.4 Strategic initiatives
    • 9.1.9 Genova Diagnostics
      • 9.1.9.1 Company overview
      • 9.1.9.2 Financial Performance
      • 9.1.9.3 Product benchmarking
      • 9.1.9.4 Strategic initiatives
    • 9.1.10 Immunodiagnostik AG
      • 9.1.10.1 Company overview
      • 9.1.10.2 Financial Performance
      • 9.1.10.3 Product benchmarking
      • 9.1.10.4 Strategic initiatives
    • 9.1.11 DNA Labs
      • 9.1.11.1 Company overview
      • 9.1.11.2 Financial Performance
      • 9.1.11.3 Product benchmarking
      • 9.1.11.4 Strategic initiatives

List of Tables

  • Table 1 List of key distributors and channel partners
  • Table 2 List of key emerging companies'/technology disruptors/innovators
  • Table 3 North America cellular health screening market, by country, 2018 to 2030 (USD Million)
  • Table 4 North America cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 5 North America cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 6 North America cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 7 North America cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 8 U.S. cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 9 U.S. cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 10 U.S. cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 11 U.S. cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 12 Canada cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 13 Canada cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 14 Canada cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 15 Canada cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 16 Europe cellular health screening market, by country, 2018 to 2030 (USD Million)
  • Table 17 Europe cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 18 Europe cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 19 Europe cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 20 Europe cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 21 Germany cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 22 Germany cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 23 Germany cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 24 Germany cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 25 U.K. cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 26 U.K. cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 27 U.K. cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 28 U.K. cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 29 France cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 30 France cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 31 France cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 32 France cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 33 Spain cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 34 Spain cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 35 Spain cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 36 Spain cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 37 Italy cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 38 Italy cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 39 Italy cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 40 Italy cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 41 Russia cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 42 Russia cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 43 Russia cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 44 Russia cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 45 Asia Pacific cellular health screening market, by country, 2018 to 2030 (USD Million)
  • Table 46 Asia Pacific cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 47 Asia Pacific cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 48 Asia Pacific cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 49 Asia Pacific cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 50 Japan cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 51 Japan cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 52 Japan cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 53 Japan cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 54 China cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 55 China cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 56 China cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 57 China cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 58 India cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 59 India cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 60 India cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 61 India cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 62 South Korea cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 63 South Korea cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 64 South Korea cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 65 South Korea cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 66 Singapore cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 67 Singapore cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 68 Singapore cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 69 Singapore cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 70 Australia cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 71 Australia cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 72 Australia cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 73 Australia cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 74 Latin America cellular health screening market, by country, 2018 to 2030 (USD Million)
  • Table 75 Latin America cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 76 Latin America cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 77 Latin America cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 78 Latin America cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 79 Brazil cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 80 Brazil cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 81 Brazil cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 82 Brazil cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 83 Mexico cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 84 Mexico cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 85 Mexico cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 86 Mexico cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 87 Argentina cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 88 Argentina cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 89 Argentina cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 90 Argentina cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 91 MEA cellular health screening market, by country, 2018 to 2030 (USD Million)
  • Table 92 MEA cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 93 MEA cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 94 MEA cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 95 MEA cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 96 South Africa cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 97 South Africa cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 98 South Africa cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 99 South Africa cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 100 Saudi Arabia cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 101 Saudi Arabia cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 102 Saudi Arabia cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 103 Saudi Arabia cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Table 104 UAE cellular health screening market, by test type, 2018 to 2030 (USD Million)
  • Table 105 UAE cellular health screening market, by single test panels, 2018 to 2030 (USD Million)
  • Table 106 UAE cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Table 107 UAE cellular health screening market, by collection site, 2018 to 2030 (USD Million)

List of Figures

  • Fig. 1 Cellular health screening market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Cellular health screening market snapshot (2021)
  • Fig. 9 Cellular health screening market: Segment snapshot (2021)
  • Fig. 10 Competitive Insights (2021)
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Cellular health screening market driver impact
  • Fig. 15 Cellular health screening market restraint impact
  • Fig. 16 Cellular health screening market industry challenges
  • Fig. 17 Porter's Five Forces Analysis
  • Fig. 18 SWOT Analysis, By Factor (Political & legal Economic and technological)
  • Fig. 19 Strategic alliance analysis
  • Fig. 20 Recent developments & impact analysis, by key market participants
  • Fig. 21 Key company market share analysis, 2021
  • Fig. 22 Company market position analysis
  • Fig. 23 Definition and scope, by test type
  • Fig. 24 Test type market share analysis, 2021 & 2030
  • Fig. 25 Segment dashboard
  • Fig. 26 Global cellular health screening market, by test type, 2018 - 2030 (USD Million)
  • Fig. 27 Single test panels market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 28 Telomere tests market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 29 Oxidative stress tests market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 30 Inflammation tests market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 31 Heavy metals tests market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 32 Multi-test panels market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 33 Definition and scope, by sample type
  • Fig. 34 Sample Type market share analysis, 2021 & 2030
  • Fig. 35 Segment dashboard
  • Fig. 36 Global cellular health screening market, by sample type, 2018 to 2030 (USD Million)
  • Fig. 37 Blood market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 38 Saliva market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 39 Serum market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 40 Urine market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 41 Definition and scope, by collection site
  • Fig. 42 Collection site market share analysis, 2021 & 2030
  • Fig. 43 Segment dashboard
  • Fig. 44 Global cellular health screening market, by collection site, 2018 to 2030 (USD Million)
  • Fig. 45 Home market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 46 Office market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 47 Hospital market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 48 Diagnostic labs market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 49 Cellular health screening market: Snapshot, 2021
  • Fig. 50 North America cellular health screening market share and leading players, 2021
  • Fig. 51 Europe cellular health screening market share and leading players, 2021
  • Fig. 52 Asia Pacific cellular health screening market share and leading players, 2021
  • Fig. 53 Latin America cellular health screening market share and leading players, 2021
  • Fig. 54 Middle East and Africa cellular health screening market share and leading players, 2021
  • Fig. 55 North America market share analysis by country, 2021
  • Fig. 56 Europe market share analysis by country, 2021
  • Fig. 57 Asia Pacific market share analysis by country, 2021
  • Fig. 58 Latin America market share analysis by country, 2021
  • Fig. 59 Middle East and Africa market share analysis by country, 2021
  • Fig. 60 North America SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 61 Europe SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 62 Asia Pacific SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 63 Latin America SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 64 Middle East and Africa SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 65 North America market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 66 U.S. market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 67 Canada market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 68 Europe market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 69 U.K. market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 70 Germany market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 71 Spain market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 72 France market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 73 Italy market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 74 Russia market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 75 Asia Pacific market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 76 China market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 77 Japan market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 78 India market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 79 Australia market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 80 South Korea market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 81 Singapore market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 82 Latin America market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 83 Brazil market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 84 Mexico market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 85 Argentina market size, & forecasts and trend analysis, 2018 to 2030 (USD Million))
  • Fig. 86 Middle East and Africa market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 87 South Africa market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 88 Saudi Arabia market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 89 UAE market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)